Commit Biologics (“Commit”), a biotechnology company pioneering complement system activation and backed by €21.5 million in ...
Everyday Health on MSN
C3G/IC-MPGN progression: Can new C3 inhibitors stop the path to dialysis?
For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of ...
Antibodies, which recognize viruses and proteins that the body has encountered before, have long gotten most of the credit for giving the human immune system a memory. Now, researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results